Klein Matthew B.
- SEC CIK
- 0001808968
In the past year, 10 open-market sale filings worth $4.41M and no purchases.
Current role at each company
- PTCT PTC Therapeutics, Inc.CHIEF EXECUTIVE OFFICERas of Aug 6, 2026
- CLPT ClearPoint Neuro, Inc.Directoras of May 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.41M
- 10 filings
- Net
- −$4.41M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Klein Matthew B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PTCT PTC Therapeutics, Inc.
CHIEF EXECUTIVE OFFICER23 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Klein Matthew B.Chief Operating Officer | SSale | −775 | $38.53 | −$29.9K | −4.5%16.5K after | |
| Apr 21, 2022 (view filing) | Apr 19 | 2 days | Klein Matthew B.CHIEF OPERATING OFFICER | SSale | −897 | $42.52 | −$38.1K | −1.6%56.6K after | |
| Jan 11, 2023 (view filing) | Jan 9 | 2 days | Klein Matthew B.CHIEF OPERATING OFFICER | SSale | −731 | $41.66 | −$30.5K | −0.9%82.4K after | |
| Jan 12, 2023 (view filing) | Jan 10-11 | 2 days | Klein Matthew B.CHIEF OPERATING OFFICER | SSale | −4.52K | $43.64 | −$197.1K | −5.5%77.9K after | 2 lots |
| Apr 20, 2023 (view filing) | Apr 18 | 2 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −1.21K | $52.04 | −$63.0K | −1.2%102.6K after | 10b5-1 |
| Jan 9, 2024 (view filing) | Jan 5 | 4 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −10.1K | $27.15 | −$274.4K | −5.7%168.2K after | 10b5-1 |
| Jan 10, 2024 (view filing) | Jan 8-9 | 2 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −7.68K | $28.90 | −$222.0K | −4.6%160.5K after | 2 lots10b5-1 |
| Apr 19, 2024 (view filing) | Apr 17 | 2 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −1.31K | $25.14 | −$32.9K | −0.6%229.2K after | 10b5-1 |
| Apr 22, 2024 (view filing) | Apr 19 | 3 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −3.36K | $24.89 | −$83.7K | −1.5%225.8K after | 10b5-1 |
| Jan 3, 2025 (view filing) | Dec 31, 2024 | 3 days | Klein Matthew B.CHIEF EXECUTIVE OFFICER | SSale | −8.28K | $45.16 | −$373.9K | −3.7%217.5K after | 10b5-1 |
CLPT ClearPoint Neuro, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing) | May 21 | 5 days | Klein Matthew B.Director | SSale | −16.0K | $11.59 | −$185.4K | −25.4%46.9K after |